Comparative study of the effect of the effect of carbadox, olaquindox and cyadox on aldosterone, sodium and potassium plasma levels in weaned pigs

To study the effects of olaquindox and cyadox on aldosterone, sodium and potassium in the blood in comparison with the effects of carbadox, weaned pigs were fed these compounds in different doses. Pigs treated with 100 and 200 ppm carbadox showed a significant decline of aldosterone after five and three weeks, respectively, compared with control values. In the 200 ppm group treatment was interrupted at week 4. With olaquindox a continuous, significant decline was found from 50 ppm and above after five weeks, and from 25 ppm and above (but excluding the 100 ppm group), after six weeks. In the cyadox groups a significant decline was measured after six weeks in the 50, 200 and 400 ppm groups. Only the 200 ppm group had an earlier response at three and five weeks. A decrease of sodium to hyponatraemic levels in the carbadox groups was seen after three weeks in the 200, and after five weeks in the 100 ppm group. In the olaquindox groups only the 200 ppm dosage showed a consistent decrease to hyponatraemic levels from four weeks treatment. In the cyadox groups the 200 ppm dosage reached a hyponatraemic level after six weeks. An increase of potassium to hyperkalaemic levels occurred at 100 and 200 ppm carbadox dosage after four and three weeks, respectively, and at 200 ppm olaquindox dosage after four weeks. No hyperkalaemic levels were seen in the cyadox groups. It is concluded that the toxic effect of olaquindox, despite minor differences, is comparable with that of carbadox but that cyadox is less toxic.     

Mice immune responses to Brucella abortus heat shock proteins. Use of baculovirus recombinant-expressing whole insect cells,purified Brucella abortus recombinant proteins,and a vaccinia virus recombinant as immunogens

Brucella abortus resists the microbicidal mechanisms of macrophages, and the expression of its heat shock proteins (HSPs) such as GroEL, GroES and HtrA may play a role in this resistance. Bacterial HSPs can be very immunogenic, inducing protective immunity in various types of bacterial infections. However, the significance of immune responses directed against B. abortus HSPs in the protection against brucellosis is currently unresolved. To elucidate the role of these proteins in protection against Brucella challenge, individual, divalent or trivalent baculovirus (BV) recombinants of B. abortus GroEL, GroES and/or HtrA were injected into BALB/c mice either as protein-expressing whole cells or as purified proteins. The preparations were given to mice in combination with Freund's or Ribi adjuvant, respectively. In addition, some mice were primed with a vaccinia virus-GroEL recombinant, followed by inoculation with purified GroEL-Ribi adjuvant combination. Antibodies were observed against B. abortus GroEL and HtrA, but not against GroES. Cellular immune response was demonstrated by observing significant IFN-gamma release by lymphocytes of mice immunized with the purified HtrA-Ribi adjuvant combination. However, none of the mice inoculated with individual, divalent or trivalent HSP-expressing cells combined with complete Freund's adjuvant or inoculated with purified B. abortus HSPs combined with Ribi adjuvant, were protected against challenge with B. abortus virulent strain 2308. Priming with vaccinia virus-GroEL recombinant and boosting with GroEL-Ribi combination did not induce protective immunity. Based on the results obtained, we suggest that although humoral and cell-mediated immune responses are induced, but protective immune response is not induced by B. abortus HSPs.     

Adverse Effects of Concurrent Carboplatin Chemotherapy and Radiation Therapy in Dogs

Background: Concurrent chemo- and radiotherapy improves outcome of certain human neoplasms but with increased signs of toxicity. Reports on adverse effects of concurrent chemo- and radiotherapy in the veterinary literature are scant.
Objective: To report adverse hematologic and gastrointestinal effects of combined carboplatin and radiation therapy in dogs.
Animals: Client-owned dogs with spontaneously occurring neoplasia.
Methods: Retrospective case study. Medical records of 65 dogs were reviewed. Criteria for inclusion were administration of radiation according to 1 of 3 fractionation schemes (19 × 3, 16 × 3, or 12 × 4 Gy) and administration of at least 1 concurrent carboplatin treatment at a dosage of 200–300 mg/m². Dog and treatment-related variables were analyzed for association with signs of intoxication.
Results: Median carboplatin dosage was 200 mg/m² (range, 200–250 mg/m²). Twelve of 58 dogs (21%) developed grade 3 or 4 neutropenia. Eleven of 56 dogs (20%) developed grade 3 or 4 thrombocytopenia. Six of 62 dogs (10%) developed grade 3, 4, or 5 gastrointestinal toxicosis. Analysis of association of dog and treatment-related variables with signs of intoxication was hampered by the small numbers of dogs in individual groups, and no statistically significant associations were found.
Conclusions and Clinical Importance: Combined modality therapy resulted in myelosuppression and gastrointestinal toxicosis. Future studies are needed to determine whether the potential benefit of combined modality therapy outweighs the risk of decreasing chemotherapy and radiation treatment intensity.     

Prevalence and intensity of Otodectes cynotis in kittens from Thessaloniki area, Greece

From May 2007 to May 2008 we have examined by otoscopy a total number of 214 cats, aged between 0 and 6 months, brought in for their first veterinary examination to a private veterinary clinic. All cats were of urban origin. In all positive cats we performed a washing of the ear using warm paraffin oil in order to determine intensity of infection. Statistical analysis was performed using the Chi-square test. A total number of 30 cats were found to be infected with Otodectes cynotis (prevalence 14.02%). Prevalence of infection was significantly (p < 0.05) higher in cats aged between 3 and 6 months (17.58%) than in cats aged below 3 months (11.38). Intensity of infection ranged between 7 and 85 (mean intensity 35.60) mites per infected cat. The same age group of cats between 3 and 6 months had significantly (p < 0.05) higher mean intensity (47.19) compared to cats aged under 3 months (22.36). No statistical significance was found between males and females for neither prevalence nor intensity. Differences and similarities with other studies are discussed.     

Advances in immunoparasitology

A selective review of the advances in immunoparasitology is presented. It is selective simply because it is not feasible to embrace the whole field of parasitology within the compass of a single review paper, for if it were attempted, it would suffer undue abbreviation. Emphasis is placed on the advances in helminthology and especially the gastro-intestinal parasites of ruminants, an obvious selection because of the interests of the author. Reviews are always somewhat retrospective in outlook; to write a review at the present time is especially foolhardy since developments in biology are such that totally new concepts can arise almost overnight, as it were. This is a particularly healthy state, and the discipline of parasitology is caught up in the application and interpretation of molecular biological considerations. "Parasitism" is a field of increasing importance and challenge.     

Ruminal escape protein supplementation and zeranol implantation effects on performance of steers grazing winter annuals.

Fifty-four crossbred steers (275 kg) were assigned randomly to one of three isoenergetic but not isonitrogenous ruminal escape protein (EP) supplements: high ruminal escape protein (HEP), low ruminal escape protein (LEP), or corn. The supplements contained corn, distillers' dried grains with solubles (DDGS), and fish meal. Supplements were fed at approximately 1.5 kg/d; the HEP and LEP supplements provided .25 and .12 kg more EP per day than corn, respectively. These supplements also supplied .20 and .10 kg more CP per day than corn. Fish meal and DDGS provided 66.7 and 33.3% of the supplemental EP, respectively. One-half of the steers in each supplement treatment were implanted once with 36 mg of zeranol. Steers grazed wheat (Triticum aestivum L.)-annual ryegrass (Lolium multiflorum Lam.) pastures for 73 d (March 1 to May 12). Daily gains (kg/d) increased linearly (P less than .07) as EP increased (HEP, 1.61; LEP, 1.54; corn, 1.47); responses were apparent only during the later periods as forage quality declined. Zeranol implants increased (P less than .02) ADG (kg/d) by 9.7% (1.58 vs 1.44). After grazing, all cattle were fed a finishing ration for 76 d. Pre-feedlot EP level produced a negative linear (P less than .04) response on feedlot ADG (kg/d) (HEP, 1.44; LEP, 1.50; corn, 1.59). Zeranol implantation during the grazing phase did not affect (P greater than .2) performance during the feedlot phase or carcass characteristics other than increased ribeye area (P less than .08). Compensatory feedlot performance negated all weight gain advantages elicited by EP supplementation during the grazing period.(ABSTRACT TRUNCATED AT 250 WORDS)     

Analysis of serum and lymphocyte surface IgM of healthy and immunodeficient horses with monoclonal antibodies

Nine monoclonal antibodies which reacted with equine immunoglobulin (Ig)M and not other equine Ig and serum proteins were prepared. Cells producing antibodies (C 1.9) which precipitated with IgM and bound to staphylococcal protein A were triple-cloned (C 1.9/3.2) and the antibodies further characterized. Monoclonal antibody C 1.9/3.2 reacted with an IgM determinant present on serum IgM from horses of several breeds. Studies with 125I-labeled IgM revealed the presence of this determinant on all IgM molecules. The monoclonal antibody enabled quantitation of IgM in presuckling foal and adult horse sera, using rocket electrophoresis. This procedure was used because presumably it gives a positive precipitation reaction over a wide range of antigen-antibody ratios. The C 1.9/3.2 monoclonal antibody recognized an exposed mu-chain determinant on live B lymphocytes, as determined by immunofluorescence. Also, IgM-containing cells could be identified in acetone-fixed frozen sections of lymphoid tissue. Sera from several other species carry the determinant identified by C 1.9/3.2, suggesting that the reagent may be useful for IgM studies in other species.